Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for COVID-19 Inpatients
NCT04338126Phase 2Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tranexamic acid in coronavirus disease 2019 (COVID-19), sponsored by University of Alabama at Birmingham. Planned start Sep 2021; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04338126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04338126.